Summary GeneFluidics Inc. (GeneFluidics) is a medical device company that offers molecular analysis services. The company provides hospital acquired infection, pathogen identification, and antimicrobial susceptibility testing services. Its products include sensor chips, multi-channel reader, robotic automation system, point of care system and systems operation cartridges, among others. GeneFluidics' molecular analysis platform enables bioassays to perform immunoassays and genetic assays, without the use of purification. The company offers testing system and electrochemical sensor platform for molecular analysis. It serves hospitals, healthcare centers, and laboratories in different parts of the US. GeneFluidics is headquartered in Irwindale, California, the US. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company GeneFluidics Inc. - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons To Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 GeneFluidics Inc. Company Snapshot 5 GeneFluidics Inc. Company Overview 5 GeneFluidics Inc. Pipeline Products and Clinical Trials Overview 6 GeneFluidics Inc. - Pipeline Analysis Overview 8 Key Facts 8 GeneFluidics Inc. - Major Products and Services 9 GeneFluidics Inc. Pipeline Products by Development Stage 10 GeneFluidics Inc. Pipeline Products Overview 12 BSI PID/AST CentriFluidic System 12 BSI PID/AST CentriFluidic System Product Overview 12 Free T3 Assay 13 Free T3 Assay Product Overview 13 Free T4 Assay 14 Free T4 Assay Product Overview 14 T3 Assay 15 T3 Assay Product Overview 15 T4 Assay 16 T4 Assay Product Overview 16 GeneFluidics Inc. - Key Competitors 17 GeneFluidics Inc. - Key Employees 18 GeneFluidics Inc. - Locations And Subsidiaries 19 Head Office 19 Appendix 20 Methodology 20 About GlobalData 20 Contact Us 20 Disclaimer 20
List of Tables
GeneFluidics Inc. Pipeline Products and Clinical Trials Overview 6 GeneFluidics Inc. Pipeline Products by Equipment Type 6 GeneFluidics Inc. Pipeline Products by Indication 7 GeneFluidics Inc., Key Facts 8 GeneFluidics Inc., Major Products and Services 9 GeneFluidics Inc. Number of Pipeline Products by Development Stage 10 GeneFluidics Inc. Pipeline Products Summary by Development Stage 11 BSI PID/AST CentriFluidic System - Product Status 12 BSI PID/AST CentriFluidic System - Product Description 12 Free T3 Assay - Product Status 13 Free T3 Assay - Product Description 13 Free T4 Assay - Product Status 14 Free T4 Assay - Product Description 14 T3 Assay - Product Status 15 T3 Assay - Product Description 15 T4 Assay - Product Status 16 T4 Assay - Product Description 16 GeneFluidics Inc., Key Employees 18
List of Figures
GeneFluidics Inc. Pipeline Products by Equipment Type 7 GeneFluidics Inc. Pipeline Products by Development Stage 10
Global fingerprint access control systems market size is estimated to reach USD 4.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Growing safety and security concerns of individual as well as organization is projected to driRead More...
Global alpha olefins market size is likely to be valued at USD 10.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing polyethylene demand for use in plastic production is anticipated to drive market growth. Growing apRead More...
Global automotive collision repair market is expected to be valued at USD 196.97 billion by 2020, as per a new research report by Radiant Insights, Inc. The industry is expected to witness significant growth owing to increasing number of on-road vehiRead More...
Global contact lenses market size is estimated to reach USD 12.5 billion by 2020, according to a new industry report by Radiant Insights, Inc. Growing number of ophthalmic disorder observed in global population especially children is likely to driveRead More...
Global data center UPS market size is estimated to reach USD 5.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Declining tolerance levels pertaining to data loss along with amplifying acceptance of cloud computing is likelyRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.